GCTK Stock Analysis & Valuation

Company profile

GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally.

CEOPaul V. Goode

SectorHealthcare

IndustryMedical - Instruments & Supplies

Employees11

IPO dateApr 25, 2013

https://www.glucotrack.com

Valuation

Forward P/E—

EV/EBITDA-7.33

Enterprise value$161.12M

Stock splits

Jun 16, 20251:60

May 20, 20241:5

Aug 13, 20211:13

Profitability & growth

Revenue growth—

Gross margin0%

Operating margin0%

ROE173.82%▲178.30%vs FY2023

Analyst consensus

Rating—

Target price—

⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.

Earnings

Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.

Next report

Mar 30, 2026

View

EPS

Actual vs estimate by quarter

Past 3 + next est.

Q2'25

ActualEst.

-$20.36

—

Q3'25

ActualEst.

-$9.62

—

Q4'25

ActualEst.

-$4.64

—

Q1'26

Next Est.

—

Revenue

Actual vs estimate by quarter

Past 3 + next est.

Q2'25

ActualEst.

—

Q3'25

ActualEst.

—

Q4'25

ActualEst.

—

Q1'26

Next Est.

—